EP3807278
PURINONE DERIVATIVES AND THEIR USE IN TREATING CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.6.2019EP published:
31.8.2022EP application number:
19734289.2
EPO information:
European Patent Register
Max expiry date:
13.6.2039
Title in English:
PURINONE DERIVATIVES AND THEIR USE IN TREATING CANCERLanguage of the patent:
English
Timeline
Today
14.6.2019EP application
31.8.2022EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Name:
CANCER RESEARCH TECHNOLOGY LIMITEDAddress:
Angel Building 407 St. John Street, London EC1V 4AD, GB
Inventor
Name:
FINLAY, Maurice, Raymond, VerschoyleAddress:
Cambridge Cambridgeshire CB2 0AA, GB
Name:
GOLDBERG, Frederick, WoolfAddress:
Cambridge Cambridgeshire CB2 0AA, GB
Name:
HOWARD, Martin, RichardAddress:
Cambridge Cambridgeshire CB2 0AA, GB
Name:
TING, Attilla, Kuan, TsueiAddress:
Cambridge Cambridgeshire CB2 0AA, GB
Priority
Number:
201862685325 PDate:
15.6.2018Country:
US
Classification
Categories:
C07D 473/32, A61K 31/522, A61P 35/00